GLP-1 receptor agonism in cardiovascular disease prevention
Hussain Saleh
Cardiovascular diseases (CVDs) are leading cause of mortality worldwide, closely linked to risk factors such as type 2 diabetes mellitus (T2DM) and obesity. Recent advances in therapeutic strategies have identified glucagon-like peptide-1 receptor agonists (GLP-1RAs) as promising agents that extend beyond glycemic control to offer significant cardiovascular benefits. This review examines the evolv...
REVIEW | Published: 30 Dec 2024
Asia-Pacific Journal of Pharmacotherapy & Toxicology, Articles, Volume 4 (2024)